Generic drug lobby details extent of US shortages, offers possible solutions

Regulatory News

Regulatory NewsJoanne S. Eglovitch

APIsBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/PolicySupply Chain Management